IL22 and colitis: We found that the activation of Wnt/β-catenin signaling not only leads to a dramatic reduction of ILC3s but also promotes the dysfunction of ILC3s with reduced expression of IL-22, MHC-II, IL-2, GM-CSF, which further aggravates the DSS-induced colitis in mice.